These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17080215)

  • 1. Point-of-care International Normalised Ratios: UK NEQAS experience demonstrates necessity for proficiency testing of three different monitors.
    Kitchen S; Kitchen DP; Jennings I; Woods TA; Walker ID; Preston FE
    Thromb Haemost; 2006 Nov; 96(5):590-6. PubMed ID: 17080215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point of Care INR testing devices: performance of the Roche CoaguChek XS and XS Plus in the UK NEQAS BC external quality assessment programme for healthcare professionals: four years' experience.
    Kitchen DP; Kitchen S; Jennings I; Woods TA; Fitzmaurice DA; Murray ET; Walker ID
    J Clin Pathol; 2012 Dec; 65(12):1119-23. PubMed ID: 23038688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European Concerted Action on Anticoagulation. Correction of displayed international normalized ratio on two point-of-care test whole-blood prothrombin time monitors (CoaguChek Mini and TAS PT-NC) by independent international sensitivity index calibration.
    Poller L; Keown M; Chauhan N; Van Den Besselaar AM; Tripodi A; Shiach C; Jespersen J;
    Br J Haematol; 2003 Sep; 122(6):944-9. PubMed ID: 12956765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International normalized ratio monitoring of vitamin K antagonist therapy: comparative performance of point-of-care and laboratory-derived testing.
    Bonar R; Mohammed S; Favaloro EJ
    Semin Thromb Hemost; 2015 Apr; 41(3):279-86. PubMed ID: 25839866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishing an external quality assessment scheme for point-of-care international normalized ratio in Thailand.
    Tientadakul P; Chuntarut A
    Int J Lab Hematol; 2015 Aug; 37(4):509-14. PubMed ID: 25529559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bridging the gap between point-of-care testing and laboratory testing in hemostasis.
    Kitchen DP; Jennings I; Kitchen S; Woods TA; Walker ID
    Semin Thromb Hemost; 2015 Apr; 41(3):272-8. PubMed ID: 25775047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of point-of-care instruments designed for monitoring oral anticoagulation with standard laboratory methods.
    Gosselin R; Owings JT; White RH; Hutchinson R; Branch J; Mahackian K; Johnston M; Larkin EC
    Thromb Haemost; 2000 May; 83(5):698-703. PubMed ID: 10823265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality assurance program for whole blood prothrombin time-international normalized ratio point-of-care monitors used for patient self-testing to control oral anticoagulation.
    Tripodi A; Bressi C; Carpenedo M; Chantarangkul V; Clerici M; Mannucci PM
    Thromb Res; 2004; 113(1):35-40. PubMed ID: 15081563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability of international normalised ratios from two point of care test systems: comparison with conventional methods.
    Poller L; Keown M; Chauhan N; van den Besselaar AM; Tripodi A; Shiach C; Jespersen J
    BMJ; 2003 Jul; 327(7405):30. PubMed ID: 12842954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The reliability of point-of-care prothrombin time testing. A comparison of CoaguChek S and XS INR measurements with hospital laboratory monitoring.
    Ryan F; O'Shea S; Byrne S
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e26-33. PubMed ID: 19032373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two point-of-care international normalized ratio devices and laboratory method.
    Vazquez SR; Fleming RP; Johnson SA
    Blood Coagul Fibrinolysis; 2017 Oct; 28(7):534-539. PubMed ID: 28379875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality assessment in point-of-care coagulation testing.
    Kitchen DP; Kitchen S; Jennings I; Woods T; Walker I
    Semin Thromb Hemost; 2008 Oct; 34(7):647-53. PubMed ID: 19085765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy and clinical usefulness of the CoaguChek S and XS Point of Care devices when starting warfarin in a hospital outreach setting.
    Sobieraj-Teague M; Daniel D; Farrelly B; Coghlan D; Gallus A
    Thromb Res; 2009 Apr; 123(6):909-13. PubMed ID: 19042011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A global quality control system to check PT-INR portable monitor for Antivitamin K antagonists.
    Testa S; Paoletti O; Bassi L; Dellanoce C; Morandini R; Lippi G
    Int J Lab Hematol; 2015 Feb; 37(1):71-8. PubMed ID: 24731219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European Concerted Action on Anticoagulation (ECAA). Minimum number of centres for reliable International Sensitivity Index calibration of CoaguChek and TAS point-of-care whole blood monitors.
    Poller L; Keown M; Chauhan N; van den Besselaar AM; Tripodi A; Shiach C; Jespersen J;
    Thromb Res; 2002 Jul; 107(1-2):61-6. PubMed ID: 12413591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of capillary whole blood international normalized ratio on the CoaguChek S, CoaguChek XS, and i-STAT 1 point-of-care analyzers.
    Karon BS; McBane RD; Chaudhry R; Beyer LK; Santrach PJ
    Am J Clin Pathol; 2008 Jul; 130(1):88-92. PubMed ID: 18550476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy and precision of the TAS analyser for near-patient INR testing by non-pathology staff in the community.
    Cachia PG; McGregor E; Adlakha S; Davey P; Goudie BM
    J Clin Pathol; 1998 Jan; 51(1):68-72. PubMed ID: 9577376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inaccuracy of point-of-care international normalized ratio in rivaroxaban-treated patients.
    Baruch L; Sherman O
    Ann Pharmacother; 2013 Sep; 47(9):1210-2. PubMed ID: 24259738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A national field study of quality assessment of CoaguChek point-of-care testing prothrombin time monitors.
    Meijer P; Kluft C; Poller L; van der Meer FJ; Keown M; Ibrahim S; van den Besselaar AM; Tripodi A; Jespersen J
    Am J Clin Pathol; 2006 Nov; 126(5):756-61. PubMed ID: 17050073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point-of-care testing and INR within-subject variation in patients receiving a constant dose of vitamin K antagonist.
    van den Besselaar AM; Biedermann JS; Kruip MJ
    Thromb Haemost; 2015 Nov; 114(6):1260-7. PubMed ID: 26202616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.